Science Explorer Back to mapMap
Discussion
Company · Derio · Spain

Fastbase Solutions (Spain)

fastbasesolutions.comROR OpenAlex
Research works
2
▼ 88% vs 2018-21
Citations
33
15.6 per fractional work
Top-10% rate
31.8%
all institutions 10.0%
Open access
100%
world 40%
International
34%
world 18%
Fastbase Solutions (Spain)

Not ranked overall: Fastbase Solutions (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Fastbase Solutions (Spain) work in?

In all years, 45% of research at Fastbase Solutions (Spain) is in Physical Sciences, 27% in Life Sciences. Its largest fields are Computer Science (45%), Medicine (27%), Biochemistry, Genetics and Molecular Biology (18%).

Physical Sciences: 1 fractional works · 45.5% of its workComputer Science: 1 fractional works · 45.5% of its workLife Sciences: 1 fractional works · 27.3% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 18.2% of its workImmunology and Microbiology: 0 fractional works · 9.1% of its workHealth Sciences: 1 fractional works · 27.3% of its workMedicine: 1 fractional works · 27.3% of its workALL ITS WORKFastbaseSolutions (Spain)2fractional works, all years
Life Sciences27%Physical Sciences45%Health Sciences27%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Computer Science145.5%
    1. Biochemistry, Genetics and Molecular Biology018.2%
    2. Immunology and Microbiology09.1%
    1. Medicine127.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Fastbase Solutions (Spain)?

The most cited paper from Fastbase Solutions (Spain) is "Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts" (Michele Bortolomeazzi et al., 2021), with 153 citations. Next come "Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer" (84) and "High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment" (49).

Most cited papers
#PaperReleasedCitations
1 Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts Michele Bortolomeazzi et al. · Gastroenterology Open access 28 Jun 2021 153
2 Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer Lissete Sánchez‐Magraner et al. · Journal of Clinical Oncology Open access 23 Feb 2023 84
3 High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment Lissete Sánchez‐Magraner, James Miles, Claire L. Baker et al. · Cancer Research Open access 27 Aug 2020 49
4 Quantification of PD-1/PD-L1 Interaction between Membranes from PBMCs and Melanoma Samples Using Cell Membrane Microarray and Time-Resolved Förster Resonance Energy Transfer Lissete Sánchez‐Magraner, Miguel de la Fuente, Charles Hall Evans et al. · Analytica—A Journal of Analytical Chemistry and Chemical Analysis Open access 13 Oct 2021 10
5 Quantification of biomarker functionality predicts patient outcomes Banafshé Larijani, James Miles, Stephen Geoffrey Ward et al. · British Journal of Cancer Open access 15 Mar 2021 9
All 12 most cited papers, with filters and sorting

Which research topics does Fastbase Solutions (Spain) publish most on?

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Ferroptosis and cancer prognosis and Immune Cell Function and Interaction.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 0 works
  2. 2 Immunotherapy and Immune Responses Immunology 0 works
  3. 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  4. 4 Immune Cell Function and Interaction Immunology 0 works
  5. 5 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available100.0%

World: 40% of research is openly available.

with international co-authors34.5%domestic only65.5%

World: 18% is written across borders.

How has Fastbase Solutions (Spain)'s research output changed?

Output in 2022-2025 was 88% lower than in 2018-2021.

Other research institutions in Derio

All research institutions in Derio

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Fastbase Solutions (Spain). Posts are plain text and can be reported.